123 related articles for article (PubMed ID: 11808957)
1. Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
Okai T; Mouri H; Yamaguchi Y; Nakanuma Y; Sawabu N
Am J Gastroenterol; 2002 Jan; 97(1):209-10. PubMed ID: 11808957
[No Abstract] [Full Text] [Related]
2. Troglitazone: a new drug for type 2 diabetes mellitus.
Deb P; Bhatia E
Natl Med J India; 1998; 11(2):81-2. PubMed ID: 9624868
[No Abstract] [Full Text] [Related]
3. Troglitazone.
Santiago JV
Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
[No Abstract] [Full Text] [Related]
4. The thiazolidinediones or "glitazones" a treatment option for type 2 diabetes mellitus.
Brown MN
Med Health R I; 2000 Apr; 83(4):118-20. PubMed ID: 10821014
[TBL] [Abstract][Full Text] [Related]
5. [Thiazolidindiones in type II diabetes mellitus].
Bornkessel B
Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
[No Abstract] [Full Text] [Related]
6. Ways of changing sensitivity to insulin.
Indian J Med Sci; 1997 Dec; 51(12):481. PubMed ID: 9715548
[No Abstract] [Full Text] [Related]
7. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
8. Severe but reversible hepatitis induced by troglitazone.
Schiano T; Dolehide K; Hart J; Baker AL
Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
[No Abstract] [Full Text] [Related]
9. A treatment for Mr WP: thiazolidinediones after troglitazone.
Montague CT
Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
[No Abstract] [Full Text] [Related]
10. Troglitazone: monotherapy indication.
Lisi DM
Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
[No Abstract] [Full Text] [Related]
11. Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.
Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Morioka S; Akasaka T; Yoshida K
Am J Cardiol; 2002 Feb; 89(3):318-22. PubMed ID: 11809434
[No Abstract] [Full Text] [Related]
12. Thiazolidinediones--a means to endpoint intervention.
Jerkins TW
Tenn Med; 2000 Nov; 93(11):403-5. PubMed ID: 11077884
[No Abstract] [Full Text] [Related]
13. Rezulin (troglitazone) greatly increases cyclosporine metabolism.
Frantz RP; Nguyen TT
J Heart Lung Transplant; 1998 Oct; 17(10):1037-8. PubMed ID: 9811416
[No Abstract] [Full Text] [Related]
14. [Primary prevention of diabetes mellitus by pharmacological intervention].
Noda M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
[No Abstract] [Full Text] [Related]
15. [Antimitochondrial antibody negative primary biliary cirrhosis].
Aizawa Y; Toda G
Ryoikibetsu Shokogun Shirizu; 1995; (7):527-30. PubMed ID: 8749544
[No Abstract] [Full Text] [Related]
16. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
[No Abstract] [Full Text] [Related]
17. [Combination therapy of insulin sensitizer and sulfonylurea].
Hari J
Nihon Rinsho; 1997 Nov; 55 Suppl():197-203. PubMed ID: 9434467
[No Abstract] [Full Text] [Related]
18. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
Kitaoka H
Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
[No Abstract] [Full Text] [Related]
19. [30-year-old diabetic patients mostly have type 2 diabetes. "Mature" diabetics are becoming increasingly younger].
MMW Fortschr Med; 2001 Jan; 143(4):46. PubMed ID: 11219286
[No Abstract] [Full Text] [Related]
20. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis.
Lino M; Binaut R; Noël LH; Patey N; Rustin P; Daniel L; Serpaggi J; Varaut A; Vanhille P; Knebelmann B; Grünfeld JP; Fakhouri F
Am J Kidney Dis; 2005 Sep; 46(3):e41-6. PubMed ID: 16129198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
